Back to results
US 10,881,641 B2Granted
Methods and use of compounds that bind to RelA of NF-kB
AssigneeCedars-Sinai Medical Center
InventorsRamachandran Murali, Hirotaka Kanzaki
Life of this patent
Estimating the term…
Abstract
The invention provides methods and agents that modulate RelA activity. These methods and modulators of RelA activity can be used to treat cancer progression of basal-like breast cancer, such as triple-negative breast cancer.
Claims13
A method for treating a cancer or a cancerous condition or a tumor, the method comprising administering to a subject having a cancer or cancerous condition a therapeutically effective amount of a compound, wherein the compound is
Dependencies are inferred from the claim text.